Michael G. Hanna

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial

Stefan H. Hohnloser, Ziad Hijazi, Laine Thomas et al. · European Heart Journal · 2012 · 573 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

Jan B. Vermorken, A.M.E. Claessen, Harm van Tinteren et al. · The Lancet · 1999 · 503 citations · Full text

Medicine, Immunology, Oncology +10

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

Ziad Hijazi, Johan Lindbäck, John H. Alexander et al. · European Heart Journal · 2016 · 431 citations · Full text

Medicine, Cardiology, Clinical Sciences +17

Exercise Intolerance Due to Mutations in the Cytochrome<i>b</i>Gene of Mitochondrial DNA

Antoni L. Andreu, Michael G. Hanna, Heinz Reichmann et al. · New England Journal of Medicine · 1999 · 424 citations

Life Sciences, Genetics, Molecular Genetics +15